Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Applied Genetic Technologies Corp    AGTC

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Applied Genetic Technologies Corp (NASDAQ:AGTC) reported earnings of ($0.18) per share missing Walls Streets expectations.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/13/2017 | 03:43pm CET

Applied Genetic Technologies Corp (NASDAQ:AGTC) reported Q4 2017 earnings this Morning, coming in at ($0.18) per share, missing Wall Street’s estimates of $0.14 per Share. Revenue for the quarter came in at $8.30 million beating analyst estimates of $12.39 million

Analyst Coverage For Applied Genetic Technologies Corp (NASDAQ:AGTC)
These are 3 Hold Ratings, 6 Buy Ratings .
The current consensus rating for Applied Genetic Technologies Corp (NASDAQ:AGTC) is Buy (Score: 2.67) with a consensus target price of $14.63 , a potential (195.45% upside)Recent Insider Trading for Applied Genetic Technologies Corp (NASDAQ:AGTC)

  • On 11/16/2016Ivana Magovcevic, Director, bought 3,000 with an average share price of $9.63 per share and the total transaction amounting to $28,890.00.
  • On 11/1/2016 Jeffrey D Chulay, VP, sold 1,000 with an average share price of $7.05 per share and the total transaction amounting to $7,050.00.
  • On 9/22/2016 Mark S Shearman, Insider, bought 3,000 with an average share price of $8.87 per share and the total transaction amounting to $26,610.00.
  • On 9/20/2016 Stephen W Potter, Insider, bought 1,400 with an average share price of $8.89 per share and the total transaction amounting to $12,446.00.
  • On 9/19/2016 Lawrence E Bullock, CFO, bought 10,000 with an average share price of $8.75 per share and the total transaction amounting to $87,500.00.
  • On 2/23/2015 Plc Glaxosmithkline, Major Shareholder, sold 503,150 with an average share price of $22.00 per share and the total transaction amounting to $11,069,300.00.

    Recent Trading for Applied Genetic Technologies Corp (NASDAQ:AGTC) Shares of Applied Genetic Technologies Corp closed the previous trading session at with shares trading hands.

    The post Applied Genetic Technologies Corp (NASDAQ:AGTC) reported earnings of ($0.18) per share missing Walls Streets expectations. appeared first on Market Exclusive.

    © Market Exclusive 2017, source Market Exclusive

    share with twitter share with LinkedIn share with facebook
    share via e-mail
    0
    Latest news on APPLIED GENETIC TECHNOLOGI
    11/07 APPLIED GENETIC TECHNOLOGIES : posts 1Q loss
    11/07 APPLIED GENETIC TECHNOLOGIES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL..
    11/07 APPLIED GENETIC TECHNOLOGIES CORP : Results of Operations and Financial Conditio..
    11/07 AGTC Announces Financial Results and Business Update for the Quarter Ended Se..
    10/31 AGTC to Host First Quarter Financial Results Conference Call and Webcast on N..
    10/06 AGTC and the Medical College of Wisconsin Announce Publication of Natural His..
    10/02 APPLIED GENETIC TECHNOLOGIES CORP : Earnings Review and Free Research Report: Ap..
    09/29 AGTC to Present at Upcoming Gene Therapy Conferences
    09/20 AGTC to Present at Upcoming Conferences
    09/14 APPLIED GENETIC TECHNOLOGIES CORPORA : AGTC) Files An 8-K Results of Operations ..
    More news
    News from SeekingAlpha
    11/13 EDITORS' PICKS DAILY : Is Downsizing A Fad?
    11/10 APPLIED GENETIC TECHNOLOGIES CORP. : A Forgotten Net-Net With Clear Upside Catal..
    11/07 Applied Genetic Technologies' (AGTC) CEO Sue Washer on Q1 2018 Results - Earn..
    11/07 Applied Genetic beats by $0.01, beats on revenue
    11/06 Notable earnings after Tuesday?s close
    Financials ($)
    Sales 2018 33,2 M
    EBIT 2018 -18,4 M
    Net income 2018 -17,6 M
    Debt 2018 -
    Yield 2018 -
    P/E ratio 2018 -
    P/E ratio 2019
    Capi. / Sales 2018 2,15x
    Capi. / Sales 2019 2,10x
    Capitalization 71,5 M
    Chart APPLIED GENETIC TECHNOLOGI
    Duration : Period :
    Applied Genetic Technologi Technical Analysis Chart | AGTC | US03820J1007 | 4-Traders
    Technical analysis trends APPLIED GENETIC TECHNOLOGI
    Short TermMid-TermLong Term
    TrendsNeutralBearishBearish
    Income Statement Evolution
    Consensus
    Sell
    Buy
    Mean consensus OUTPERFORM
    Number of Analysts 6
    Average target price 8,14 $
    Spread / Average Target 106%
    EPS Revisions
    Managers
    NameTitle
    Susan B. Washer President, Chief Executive Officer & Director
    William A. Sullivan Chief Financial Officer
    Mark S. Shearman Chief Scientific Officer & Vice President
    Matthew Feinsod Chief Medical Officer
    James Rosen Independent Director
    Sector and Competitors
    1st jan.Capitalization (M$)
    APPLIED GENETIC TECHNOLOGIES CORP-57.75%71
    GILEAD SCIENCES1.16%94 601
    REGENERON PHARMACEUTICALS6.67%42 072
    VERTEX PHARMACEUTICALS100.10%37 280
    GENMAB3.15%11 878
    EXELIXIS, INC.76.93%7 805